Saudi Arabia, UK sign pact on marine biodiversity protection

Riad: Saudi Arabia is adopting the future of medical care by integrating artificial intelligence and chemical -based diagnoses to provide personalized preventive care. This is part of a broader transformation that frames longevity not only as an individual aspiration but also as a national priority.

The center of this transformation is the integration of genomics, proteomics, metabolomics and other omic disciplines in clinical practice, driven by AI. Leading the position is Rewind, a company based in Saudi Arabia that uses technology to be a pioneer in proactive and individualized attention.

“In Rewind, we take advantage of the power of AI and OMICs technologies to change the medical attention of a generalized and reactive model to one that is deeply personalized and proactive,” said Dr. Walid Zaher, founder of Rewind News.

“The AI ​​is the engine that makes these fixed data processable. Identify patterns, predict health risks and recruit the most effective interventions for each individual.”

He said that “such a dynamic and data -based approach” allows medical care to be “as unique as the patient that serves.”

OMICs refers to a group of biological fields that end with the suffix “-omics”, each examining a different layer of biological data on a scale of the entire system. Together, they sacrifice an integral vision of how the body works.

The transition from this broad understanding of processable ideas requires the ability to analyze billions of variables through DNA, protein expression, metabolic changes and epigenetic changes. This capacity allows professionals to intervene earlier and more accurately than ever.

“OMICs based diagnoses have already begun to have a deep impact on the patient’s results,” said Zaher.

“The precision enabled by genomics and multiple multiple technologies allows diseases in their early molecular stages or long before clinical symptoms appear.

“Beyond disease detection, multiple multiple approaches help monitor the progression of the disease and response to treatments. The result has an increase in patient satisfaction, since they experience health results and more personalized care.”

Saudi Arabia’s commitment to health innovation is obvious in both its infrastructure and ambition. National initiatives such as the Saudi Genome and Investments Program and Saudi Genome through the Hondusion Foundation are promoting the development of a knowledge system based on aligned knowledge with Vision 2030.

“The 2030 vision of Saudi Arabia has made health innovation a strategic priority,” said Zaher. “The government has invested a great infrastructure that supports avant -garde investigation, particularly in AI, genomics and biotechnology.”

This approach is positioning Saudi Arabia as an important player in the global longevity economy, according to Dmitry Kaminskiy, co -founder and managing partner or deep knowledge group.

“Saudi Arabia and its CCG counterparts are strategically positioned to be not only participants but global pioneers in the longevity economy,” Kaminskiy told Arab News.

“With Vision 2030, the Kingdom has established the basis to integrate economic diversity, the innovation of the health and governance of AI, all the key components of a national longevity strategy.”

Kaminskiy, author of multiple books about Ia and Healthspan, believes that AI has changed a secondary role to something much more central in the field.

“Now we are witnessing a paradigm shift where AI is not only an assistant but the architect of next generation health platforms,” ​​he said. “Just as Fintech redefined personal finances, the AI ​​will redefine personal health.”

Despite these advances, there are significant challenges in the main attention of AI and OMICs based on national systems. Zaher de Rewind said that overcoming thesis obstacles will require technological and cultural changes.

“The integration of AI and precision medicine into a national health system comes with several challenges, the most pressing is the need for a robust data infrastructure,” he said.

“Medical care data is fragmented or curled, which makes it upset to create a cohesive system that can use cash.”

Another critical challenge is the training of medical care providers to commit to this new era or medicine.

Zaher said that the integration of AI and precision medicine in clinical practice requires “a level of technological literacy that has not yet been generalized throughout the health workforce.

“We need specific training programs that equate suppliers with the skills to interpret ideas generated by AI and translate them into a patient -centered care care,” he added.

Looking towards the future, Kaminskiy said that establishing ethical data governance will be vital to guarantee progress.

“The data are the soul of longevity with AI,” he said. “But it is not only the amount of data that matters: it is the property, security and ethical governance of that data that will define the winners in this domain.”

The Hondix Foundation is playing a key role in the financing and configuration of the Longevity Research Agenda in the region.

According to Zaher, he is “ready to play a fundamental role in the acceleration of global health science by providing the financing and resources necessary to promote innovation in aging research.

“Through support projects that focus on extending age -related diseases and age prevention, Hondusion is helping to establish a global standard for the science of longevity,” he added.

As Saudi Arabia expands its investment in medical care promoted by AI and global collaborations are deepened, the limits between technology, biology and medicine are bordering the objective of healthy aging closer to reality.